The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2019

Filed:

Apr. 07, 2015
Applicants:

Matthew Frieman, Hunt Valley, MD (US);

Peter B. Jarhling, Gaithersburg, MD (US);

Lisa E. Hensley, Frederick, MD (US);

Inventors:

Matthew Frieman, Hunt Valley, MD (US);

Peter B. Jarhling, Gaithersburg, MD (US);

Lisa E. Hensley, Frederick, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7068 (2006.01); A61K 31/506 (2006.01); A61K 31/5415 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61K 31/13 (2006.01); A61K 31/138 (2006.01); A61K 31/4706 (2006.01); A61K 31/522 (2006.01); A61K 31/662 (2006.01); A61K 31/675 (2006.01); A61K 31/7012 (2006.01); A61K 31/7056 (2006.01); A61K 31/7072 (2006.01); A61K 31/7125 (2006.01); A61K 31/435 (2006.01); A61K 31/46 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7068 (2013.01); A61K 31/13 (2013.01); A61K 31/138 (2013.01); A61K 31/435 (2013.01); A61K 31/46 (2013.01); A61K 31/4706 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/522 (2013.01); A61K 31/5415 (2013.01); A61K 31/55 (2013.01); A61K 31/662 (2013.01); A61K 31/675 (2013.01); A61K 31/7012 (2013.01); A61K 31/7056 (2013.01); A61K 31/7072 (2013.01); A61K 31/7125 (2013.01); A61K 38/21 (2013.01); A61K 38/212 (2013.01); A61K 38/215 (2013.01); A61K 38/217 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention provides methods for treating a coronavirus infection. For example, treatment may be effected by administering a neurotransmitter inhibitor, a signaling kinase inhibitor, an estrogen receptor inhibitor, a DNA metabolism inhibitor or an anti-parasitic agent. Also provided are methods for treating a coronavirus infection in which an anti-viral drug also is administered during any of the described methods.


Find Patent Forward Citations

Loading…